Clinical Trials Logo

Clinical Trial Summary

Host systemic responses to vigorous stimuli as trauma, surgical tissue injury, anesthesia and post-operative pain, leads to release a variety of pro-inflammatory cytokines including interleukin-1 (IL-1) and interleukin-6 (IL-6) mainly from monocytes and macrophages Thus, the rise of IL-6 is regarded as an early marker of tissue damage and its rise proportional to the degree of tissue damage .

It has been demonstrated that systemic responses to stress may be modified by the anesthetic technique used . Total intravenous anesthesia (TIVA) especially propofol based greatly suppresses the stress response induced by surgery when compared to inhalation by lowering cortisol levels.

Ketamine has the ability to modulate (modify) inflammation . Even the sub-anesthetic doses of ketamine in animal models were even provided to have an effect on the inflammatory response system in the central nervous system


Clinical Trial Description

The release a variety of pro-inflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1) and interleukin-6 (IL-6) mainly from monocytes and macrophages due to surgical trauma or anesthesia .

IL-6 is constantly found in the peripheral blood and rapidly within few minutes unlike other pro inflammatory mediators. Thus, the rise of IL-6 is regarded as an early marker of tissue damage and IL-6 levels are proportional to the degree of tissue damage . The two major actions of IL-6 are having a key role in regulating stress responses by activating the hypothalamic-pituitary- adrenal (HPA) axis and synthesizing fibrinogen (which is necessary for the acute-phase response) serving as a growth factor for activated B-cells .

While appropriate inflammatory reactions are advantageous and essential for wound healing and host defense against microorganisms, excessive immune responses can be detrimental. The released mediators prompt systemic endocrine, immunological and metabolic responses result in increased pain sensitivity, altered metabolism, hyperthermia and greater secretion of liver acute phase proteins and stress hormones, so yields unstable patient's hemodynamic status

Propofol was documented to have an advantage in terms of inflammatory and immunomodulatory effects through significant effect on TNF-α, IL-6 and IL-10 release .

Ketamine has the ability to modulate (modify) inflammation and this is why it is recommended in patients with sepsis undergoing surgery . This may be possibly related with the variations in TNF-α and nuclear factor-κB expression . Even the sub-anesthetic doses of ketamine in animal models were even provided to have an effect on the inflammatory response system in the central nervous system which is involved in its therapeutic effect on depression (Yang-2 et al., 2013).

This study will be conducted to compare between the intravenous infusion of ketamine against the intravenous infusion of propofol during general anesthesia in patients undergoing major abdominal surgeries. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03793075
Study type Interventional
Source Mansoura University Hospital
Contact Reem Abdelraouf, lecturer
Phone 01006151100
Email reemraouf64@gmail.com
Status Not yet recruiting
Phase N/A
Start date January 10, 2019
Completion date August 15, 2019

See also
  Status Clinical Trial Phase
Completed NCT01194492 - Albumin Kinetics in Generalized Inflammation Phase 4
Completed NCT00512213 - Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery N/A
Completed NCT04798040 - Effects of Lavender Aromatherapy and Cold Application on Pain During Drain Removal N/A
Completed NCT06456918 - ValidationTurkishVersionQualityofRecovery-15
Completed NCT02337010 - Continuous Central Venous Oxygen Saturation Assisted Intraoperative Hemodynamic Management N/A
Completed NCT00549419 - Arterial Pressure Based Cardiac Output for Goal-Directed Therapy in Abdominal Surgery Phase 4
Completed NCT04080479 - Bolus Versus Continuous Enteral Tube Feeding N/A
Recruiting NCT03295851 - Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial Phase 4
Withdrawn NCT01403909 - Effect of Pneumatic Intermittent Venous Compression on Fluid Volumes Infused During Major Abdominal Surgery N/A
Recruiting NCT02534012 - Paravertebral Block vs. General Anesthesia for Major Abdominal Surgery N/A
Completed NCT05365113 - Comparison of Hemodynamic Effects of Two Modalities of Alveolar Recruitment Maneuvers in Major Abdominal Surgery Patients N/A
Recruiting NCT05276596 - Evaluation of the Early Use of Norepinephrine in Major Abdominal Surgery on Postoperative Organ Dysfunction N/A
Completed NCT01075646 - Local Anesthesia Versus Saline Serum in Surgical Incision of Colorectal or Hepatic Surgery Phase 4
Completed NCT04935814 - Cardiac Output Response to Vasopressin Infusion In Abdominal Surgery Patients Under Mechanical Ventilation Phase 4
Completed NCT04345354 - Observational Study of the Value of Using Obstructive Sleep Apnea-hypopnea Syndrome (CPAP) Ventilation on the Occurrence of Respiratory and Cardiovascular Complications in Patients at High Risk of Obstructive Apnea Syndrome During Postoperative Sleep Surgery of a Major Abdominal Surgery.
Recruiting NCT06285526 - Glycocalyx Monitoring in Major Abdominal Surgery
Completed NCT03166644 - Individualized Goal-directed Sufentanil Administration Versus Standard Therapy in Patients Undergoing Major Abdominal Surgery N/A
Completed NCT04480775 - Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block Phase 2/Phase 3
Completed NCT05795608 - Effectivity of Incentive Spirometry on Postoperative Pulmonary Complication After Major Abdominal Surgery N/A
Completed NCT02142816 - Fluid Requirement During Surgery PVI v Doppler N/A